Please login to the form below
TOPRA regulatory intelligence network
The Organisation for Professionals in Regulatory Affairs (TOPRA) is to launch a special interest network (SPIN) to drive regulatory intelligence
The Organisation for Professionals in Regulatory Affairs (TOPRA) is to launch a special interest network (SPIN) to drive regulatory intelligence.
The aim of this group will be to explore and share ideas and methods used for regulatory intelligence, and will be formed from TOPRA members. It will be launched on February 23 in London.
As the framework for the regulation of medicines grows ever more complex, it is becoming increasingly hard to predict how regulatory agencies will view applications.
In addition, more and more information is becoming available, a trend that will continue with the drive for greater transparency. Consequently, TOPRA believes it is important to know how to find this information, filter it and analyse it in ways that can increase understanding of the expectations of the regulatory agencies at both the national and international levels.
TOPRA members wanting further information on this SPIN should email: spin@topra.org
Share
Related Hub content
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
